Scientists at the Volga Research Medical University began developing a method for detecting minimal residual tumor or its recurrence in patients with cancerous tumors. Now the technique is being tested on colorectal cancer, melanoma and lung adenocarcinoma. This was reported to socialbites.ca in the press service of the program “Priority 2030” of the Ministry of Education and Science of Russia.
This technique will make it possible to detect residual tumors, both with and without a known source of uncontrolled division of tumor cells (driver mutations). In the latter case, DNA analysis of the tumor is used to look for mutations.
Head of the Department of Oncology, Radiation Therapy and Radiation Diagnosis VI Professor NE Yakhontova Anna Maslennikova.
The work of scientists will form the basis of the individual treatment program of cancer patients after surgical treatment. The program is scheduled to be implemented by February 2024.
So far, researchers have developed the PCR technique needed to obtain sufficient tumor DNA, as well as a DNA sequencing technique to look for driver mutations in blood samples from patients.
The research is carried out within the framework of the strategic project “Basic oncology: from experiment to clinic”, the national project “Science and Universities” of the “Priority-2030” program.
ancient scientists to solveWhen men younger than 49 need screening for colon and rectal cancer.